Literature DB >> 17379129

Dexmedetomidine for conscious sedation in difficult awake fiberoptic intubation cases.

Sergio D Bergese1, Babak Khabiri, William D Roberts, Michael B Howie, Thomas D McSweeney, Mark A Gerhardt.   

Abstract

Currently used methods of sedation for fiberoptic intubation such as benzodiazepines, propofol, or opioids have their limitations. Dexmedetomidine (DEX) is a selective alpha-2 adrenergic agonist that has been used clinically for its sympatholytic, analgesic, and sedative properties. We report on 4 patients with particularly difficult airways who underwent successful awake fiberoptic intubation with DEX. Dexmedetomidine was used to provide a moderate level of conscious sedation without causing respiratory distress or hemodynamic instability during fiberoptic intubation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379129     DOI: 10.1016/j.jclinane.2006.07.005

Source DB:  PubMed          Journal:  J Clin Anesth        ISSN: 0952-8180            Impact factor:   9.452


  28 in total

1.  Dexmedetomidine in current anaesthesia practice- a review.

Authors:  Shagufta Naaz; Erum Ozair
Journal:  J Clin Diagn Res       Date:  2014-10-20

Review 2.  Dexmedetomidine for the management of awake fibreoptic intubation.

Authors:  Xing-Ying He; Jian-Ping Cao; Qian He; Xue-Yin Shi
Journal:  Cochrane Database Syst Rev       Date:  2014-01-19

3.  Dexmedetomidine as sole agent for awake fiberoptic intubation in a patient with local anesthetic allergy.

Authors:  Maxime Madhere; David Vangura; Alik Saidov
Journal:  J Anesth       Date:  2011-05-07       Impact factor: 2.078

4.  Update on dexmedetomidine: use in nonintubated patients requiring sedation for surgical procedures.

Authors:  Mohanad Shukry; Jeffrey A Miller
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

5.  Dexmedetomidine versus remifentanil sedation during awake fiberoptic nasotracheal intubation: a double-blinded randomized controlled trial.

Authors:  Rong Hu; J X Liu; Hong Jiang
Journal:  J Anesth       Date:  2012-10-17       Impact factor: 2.078

6.  Dexmedetomidine-fentanyl versus propofol-fentanyl in flexible bronchoscopy: A randomized study.

Authors:  Feng Yuan; Hongguang Fu; Pengju Yang; Kai Sun; Shubiao Wu; Miaomiao Lv; Zhenzhen Dong; Tieli Dong
Journal:  Exp Ther Med       Date:  2016-04-20       Impact factor: 2.447

7.  Dexmedetomidine premedication for fiberoptic intubation in patients of temporomandibular joint ankylosis: A randomized clinical trial.

Authors:  Kumkum Gupta; Manish Jain; Prashant K Gupta; Bhawna Rastogi; Sanjeev K Saxena; Aman Manngo
Journal:  Saudi J Anaesth       Date:  2012-07

8.  Dexmedetomidine is effective for monitored anesthesia care in outpatients undergoing cataract surgery.

Authors:  Hyo-Seok Na; In-Ae Song; Hong-Sik Park; Jung-Won Hwang; Sang-Hwan Do; Chong-Soo Kim
Journal:  Korean J Anesthesiol       Date:  2011-12-20

9.  Subcutaneous dissociative conscious sedation (sDCS) an alternative method for airway regional blocks: a new approach.

Authors:  Mihan J Javid
Journal:  BMC Anesthesiol       Date:  2011-10-26       Impact factor: 2.217

10.  Dexmedetomidine versus Remifentanil for Sedation during Awake Fiberoptic Intubation.

Authors:  Davide Cattano; Nicholas C Lam; Lara Ferrario; Carmen Seitan; Kash Vahdat; Darrell W Wilcox; Carin A Hagberg
Journal:  Anesthesiol Res Pract       Date:  2012-07-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.